Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
QuintilesIMS
Chubb
Julphar
Queensland Health
Baxter
Cantor Fitzgerald
US Department of Justice
Citi

Generated: November 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022277

« Back to Dashboard

NDA 022277 describes TEMODAR, which is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TEMODAR profile page.

The generic ingredient in TEMODAR is temozolomide. There are sixteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the temozolomide profile page.
Summary for 022277
Tradename:TEMODAR
Applicant:Merck Sharp Dohme
Ingredient:temozolomide
Patents:3
Formulation / Manufacturing:see details
Pharmacology for NDA: 022277
Mechanism of ActionAlkylating Activity
Suppliers and Packaging for NDA: 022277
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TEMODAR temozolomide POWDER;INTRAVENOUS 022277 NDA Merck Sharp & Dohme Corp. 0085-1381 0085-1381-01 1 VIAL, SINGLE-USE in 1 CARTON (0085-1381-01) > 40 mL in 1 VIAL, SINGLE-USE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;INTRAVENOUSStrength100MG/VIAL
Approval Date:Feb 27, 2009TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Sep 8, 2023Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Feb 21, 2023Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Feb 21, 2023Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Fish and Richardson
Cipla
Covington
Julphar
QuintilesIMS
Dow
Johnson and Johnson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.